Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata is a complex condition causing hair loss, linked to genetics and immune system issues, and may be related to other autoimmune diseases; treatments vary in effectiveness.

The Polish Society of Dermatology recommends treatments for alopecia areata that vary by severity, including topical and systemic medications, with long-term maintenance important for management.

Reducing the dose of Baricitinib to 2mg still helped over half of the patients with severe scalp alopecia maintain their hair regrowth after two years.

JAK inhibitors effectively improve hair regrowth in alopecia areata with an acceptable safety profile.

Tofacitinib 2% ointment helped hair regrow in 3 out of 10 patients with alopecia areata, but caused side effects like scalp irritation and raised cholesterol in some.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Baricitinib and ritlecitinib are recommended for severe alopecia areata, with other treatments available off-label.

Brepocitinib 30mg is most effective for moderate-to-severe alopecia areata, but ritlecitinib 50mg may offer a better balance of safety and effectiveness.

Tofacitinib shows promise for treating severe alopecia areata with good safety and effectiveness.

Hydroxychloroquine is less effective than betamethasone oral mini pulse therapy for treating alopecia areata.

Measuring bald patch size can help grade hair loss severity, with photograph-based evaluation being more reliable.

Hypothyroidism is often linked to the hair loss condition telogen effluvium.

Baricitinib helps grow eyebrows and eyelashes in severe alopecia areata patients.

Topical calcipotriol successfully treated hair loss in three patients with Alopecia Totalis.

Oral tofacitinib may effectively treat hair loss in children with alopecia areata.

Methotrexate may effectively and safely treat hair loss in children, with notable improvement after 12-15 months.

COVID-19 doesn't make alopecia areata worse.

Trichoscopy is useful for diagnosing and monitoring alopecia areata treatment.

A young child with complete hair loss improved significantly with a combination of hair growth treatments and laser therapy.

Tofacitinib regrew hair in a man with total hair loss but raised cytokine levels, needing more research on possible side effects.

Combining pulsed prednisone with tofacitinib can lead to lasting hair regrowth in severe alopecia areata patients.

Anionic surfactants significantly improve the foaming of minoxidil gel shampoo.

Topical corticosteroids may be a safe and effective treatment for severe alopecia areata in children.

Using minoxidil and tofacitinib together can effectively treat severe hair loss.

Baricitinib therapy helped many patients with severe alopecia regrow hair after 52 weeks.

Baricitinib was effective in regrowing hair in patients with different levels of alopecia areata severity.

Using growth factors and microneedling shows promise for hair regrowth in Alopecia Areata, but more research is needed.

Both Th1 and Th2 immune responses are increased in alopecia areata, with Th2 response more strongly linked to how severe the disease is.

Synthetic hormone treatment reduces melanin and hair growth in rats.

Higher granulysin levels in the blood are linked to more severe hair loss in alopecia areata patients, and these levels decrease after effective treatment.